Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 5-FLUOROURACIL TREATMENT OF LIVER METASTASES BY CONTINUOUS HEPATIC ARTERY INFUSION VIA COURNAND CATHETER: RESULTS AND SUITABILITY FOR INTENSIVE POSTSURGICAL ADJUVANT CHEMOTHERAPY.

Literature DB >> 14064976

5-FLUOROURACIL TREATMENT OF LIVER METASTASES BY CONTINUOUS HEPATIC ARTERY INFUSION VIA COURNAND CATHETER: RESULTS AND SUITABILITY FOR INTENSIVE POSTSURGICAL ADJUVANT CHEMOTHERAPY.

M J BRENNAN, R W TALLEY, E H DRAKE, V K VAITKEVICIUS, A K POZNANSKI, B E BRUSH.

Abstract

Entities: Chemical

Keywords: ADENOCARCINOMA; FLUOROURACIL; GASTROINTESTINAL NEOPLASMS; ISOLATION PERFUSION; LIVER NEOPLASMS; MALIGNANT CARCINOID SYNDROME; NEOPLASM METASTASIS

Mesh：

Substances：
Fluorouracil

Year: 1963 PMID： 14064976 PMCID： PMC1408391 DOI： 10.1097/00000658-196309000-00009

Source DB: PubMed Journal: Ann Surg ISSN： 0003-4932 Impact factor: 12.969

× No keyword cloud information.

18 in total

1. Fluorinated pyrimidines in treatment of breast cancer patients with liver metastases.

Authors: T L DAO; R GRINBERG
Journal: Cancer Chemother Rep Date: 1963-03

2. The distribution of tritiated thymidine in adult BALB/cJ and C57BL/6J mice.

Authors: R G SHORTER; J L TITUS
Journal: Proc Staff Meet Mayo Clin Date: 1962-12-05

3. Experience with fluorinated pyrimidines in adenocarcinoma of the lower intestinal tract.

Authors: R R ELLISON
Journal: N Y State J Med Date: 1962-07-15

4. Effects of continuous hepatic artery infusion of antimetabolites on primary and metastatic cancer of the liver.

Authors: B CLARKSON; C YOUNG; W DIERICK; P KUEHN; M KIM; A BERRETT; P CLAPP; W LAWRENCE
Journal: Cancer Date: 1962 May-Jun Impact factor: 6.860

5. Clinical evaluation of cancer chemotherapy with 5-fluorouracil.

Authors: V K VAITKEVICIUS; M J BRENNAN; V L BECKETT; J E KELLY; R W TALLEY
Journal: Cancer Date: 1961 Jan-Feb Impact factor: 6.860

6. 5-Fluorouracil in clinical cancer experience with 155 patients.

Authors: M J BRENNAN; V K VAITKEVICIUS
Journal: Cancer Chemother Rep Date: 1960-02

7. THE MODE OF ACTION OF 5-FLUOROURACIL AND ITS DERIVATIVES.

Authors: S S Cohen; J G Flaks; H D Barner; M R Loeb; J Lichtenstein
Journal: Proc Natl Acad Sci U S A Date: 1958-10-15 Impact factor: 11.205

8. Use of 5-fluorouracil in disseminated solid neoplasms.

Authors: D B ROCHLIN; J SHINER; E LANGDON; R OTTOMAN
Journal: Ann Surg Date: 1962-07 Impact factor: 12.969

9. Chronic infusion of tritiated thymidine into mice with tumors.

Authors: M L MENDELSOHN
Journal: Science Date: 1962-01-19 Impact factor: 47.728

10. Studies on fluorinated pyrimidines. III. The metabolism of 5-fluorouracil-2-C14 and 5-fluoroorotic-2-C14 acid in vivo.

Authors: N K CHAUDHURI; B J MONTAG; C HEIDELBERGER
Journal: Cancer Res Date: 1958-04 Impact factor: 12.701

9 in total

6. Safety of redo hepatectomy for colorectal liver metastases after selective interarterial radiation therapy: a case report.

Authors: Kyriakos Neofytou; Harpreet Wasan; Satvinder Mudan
Journal: Case Rep Surg Date: 2014-03-04

5-FLUOROURACIL TREATMENT OF LIVER METASTASES BY CONTINUOUS HEPATIC ARTERY INFUSION VIA COURNAND CATHETER: RESULTS AND SUITABILITY FOR INTENSIVE POSTSURGICAL ADJUVANT CHEMOTHERAPY.

1. Fluorinated pyrimidines in treatment of breast cancer patients with liver metastases.

2. The distribution of tritiated thymidine in adult BALB/cJ and C57BL/6J mice.

3. Experience with fluorinated pyrimidines in adenocarcinoma of the lower intestinal tract.

4. Effects of continuous hepatic artery infusion of antimetabolites on primary and metastatic cancer of the liver.

5. Clinical evaluation of cancer chemotherapy with 5-fluorouracil.

6. 5-Fluorouracil in clinical cancer experience with 155 patients.

7. THE MODE OF ACTION OF 5-FLUOROURACIL AND ITS DERIVATIVES.

8. Use of 5-fluorouracil in disseminated solid neoplasms.

9. Chronic infusion of tritiated thymidine into mice with tumors.

10. Studies on fluorinated pyrimidines. III. The metabolism of 5-fluorouracil-2-C14 and 5-fluoroorotic-2-C14 acid in vivo.

Review 1. Progress report. Cytotoxic therapy for gastrointestinal carcinoma.

2. Hepatic artery infusion of melphalan in patients with liver metastases from ocular melanoma.

Review 3. Complications of hepatic artery infusion: a review of 4580 reported cases.

Review 4. Studies on the treatment and prevention of colorectal liver metastases.

5. Anatomical basis and histopathological changes resulting from selective internal radiotherapy for liver metastases.

6. Safety of redo hepatectomy for colorectal liver metastases after selective interarterial radiation therapy: a case report.

7. Personalizing colon cancer therapeutics: targeting old and new mechanisms of action.

8. The blood supply of colorectal liver metastases.

9. Results of 27 cases with hepatic metastases treated by combination chemotherapy.